Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration
 Pursuant to § 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on July 16, 2009, Cerilliant Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78665-2402, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II: Drug
ScheduleCathinone (1235)
IMethcathinone (1237)
IN-Ethylamphetamine (1475)
IN,N-Dimethylamphetamine (1480)
IAminorex (1585)
I4-Methylaminorex (cis isomer) (1590)
IGamma-Hydroxybutyric acid (2010)
IMethaqualone (2565)
IAlpha-ethyltryptamine (7249)
ILysergic acid diethylamide (7315)
I2,5-Dimethoxy-4-(n)-propylthiophenethylamine (7348)
IMarihuana (7360)
ITetrahydrocannabinols (7370)
IMescaline (7381)
I3,4,5-Trimethoxyamphetamine (7390)
I4-Bromo-2,5-dimethoxyamphetamine (7391)
I4-Bromo-2,5-dimethoxyphenethylamine (7392)
I4-Methyl-2,5-dimethoxyamphetamine (7395)
I2,5-Dimethoxyamphetamine (7396)
I2,5-Dimethoxy-4-ethylamphetamine (7399)
I3,4-Methylenedioxyamphetamine (7400)
I5-Methoxy-3,4-methylenedioxyamphetamine (7401)
IN-Hydroxy-3,4-methylendioxyamphetamine (7402)
I3,4-Methylendioxy-N-ethylamphetamine (7404)
I3,4-Methylenedioxymethamphetamine (7405)
I4-Methoxyamphetamine (7411)
IAlpha-methyltryptamine (7432)
IBufotenine (7433)
IDiethyltryptamine (7434)
IDimethyltryptamine (7435)
IPsilocybin (7437)
IPsilocyn (7438)
I5-Methoxy-N,N-diisopropyltyptamine (7439)
IN-Benzylpiperazine (7493)
IAcetyldihydrocodeine (9051)
IBenzylmorphine (9052)
ICodeine-N-oxide (9053)
IDihydromorphine (9145)
I( print page 69465)Heroin (9200)
IHydromorphinol (9301)
IMethyldihydromorphine (9304)
IMorphine-N-oxide (9307)
INormorphine (9313)
IPholcodine (9314)
IAcetylmethadol (9601)
IAllylprodine (9602)
IAlphacetylmethadol except levo-alphacetylmethadol (9603)
IAlphameprodine (9604)
IAlphamethadol (9605)
IBetacetylmethadol (9607)
IBetameprodine (9608)
IBetamethadol (9609)
IBetaprodine (9611)
IHydroxypethidine (9627)
INoracymethadol (9633)
INorlevorphanol (9634)
INormethadone (9635)
ITrimeperidine (9646)
IPhenomorphan (9647)
I1-Methyl-4-phenyl-4-propionoxypiperidine (9661)
ITilidine (9750)
IPara-Fluorofentanyl (9812)
I3-Methylfentanyl (9813)
IAlpha-Methylfentanyl (9814)
IAcetyl-alpha-methylfentanyl (9815)
IBeta-hydroxyfentanyl (9830)
IBeta-hydroxy-3-methylfentanyl (9831)
IAlpha-Methylthiofentanyl (9832)
I3-Methylthiofentanyl (9833)
IThiofentanyl (9835)
IAmphetamine (1100)
IIMethamphetamine (1105)
IILisdexamfetamine (1205)
IIPhenmetrazine (1631)
IIMethylphenidate (1724)
IIAmobarbital (2125)
IIPentobarbital (2270)
IISecobarbital (2315)
IIGlutethimide (2550)
IINabilone (7379)
II1-Phenylcyclohexylamine (7460)
IIPhencyclidine (7471)
II1-Piperidinocyclohexanecarbonitrile (8603)
IIAlphaprodine (9010)
IICocaine (9041)
IICodeine (9050)
IIDihydrocodeine (9120)
IIOxycodone (9143)
IIHydromorphone (9150)
IIDiphenoxylate (9170)
IIBenzoylecgonine (9180)
IIEthylmorphine (9190)
IIHydrocodone (9193)
IILevomethorphan (9210)
IILevorphanol (9220)
IIIsomethadone (9226)
IIMeperidine (9230)
IIMeperidine intermediate-A (9232)
IIMeperidine intermediate-B (9233)
IIMeperidine intermediate-C (9234)
IIMethadone (9250)
IIMethadone intermediate (9254)
IIDextropropoxyphene, bulk (non-dosage forms) (9273)
IIMorphine (9300)
IIThebaine (9333)
IILevo-alphacetylmethadol (9648)
IIOxymorphone (9652)
IINoroxymorphone (9668)
IIRacemethorphan (9732)
IIAlfentanil (9737)
IISufentanil (9740)
IITapentadol (9780)
II( print page 69466)Fentanyl (9801)
II
 The company plans to manufacture small quantities of the listed controlled substances to make reference standards which will be distributed to their customers. Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than January 11, 2011. Dated: November 1, 2010. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.


[FR Doc. 2010-28516 Filed 11-10-10; 8:45 am] BILLING CODE 4410-09-P